Form 8-K - Current report:
SEC Accession No. 0001213900-25-012244
Filing Date
2025-02-11
Accepted
2025-02-11 16:35:12
Documents
23
Period of Report
2025-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0229914-8k_oramed.htm   iXBRL 8-K 58204
2 ANCILLARY AGREEMENT COMPLETION PROTOCOL AND SUPPLEMENTAL AGREEMENT, DATED AS OF ea022991401ex10-1_oramed.htm EX-10.1 354367
3 FORM OF REGISTRATION RIGHTS AGREEMENT, TO BE EXECUTED BY AND AMONG ORAMED PHARMA ea022991401ex10-2_oramed.htm EX-10.2 99533
4 ASSET TRANSFER AGREEMENT, DATED AS OF FEBRUARY 7, 2025, BY AND AMONG ORAMED PHAR ea022991401ex10-3_oramed.htm EX-10.3 191672
5 SUPPLY AGREEMENT, DATED AS OF FEBRUARY 7, 2025, BY AND AMONG ORAMED NEWCO, INC., ea022991401ex10-4_oramed.htm EX-10.4 152320
6 LICENSE AGREEMENT, DATED AS OF FEBRUARY 7, 2025, BY AND AMONG ORAMED NEWCO, INC. ea022991401ex10-5_oramed.htm EX-10.5 109751
7 NOVATION AGREEMENT AND RELEASE, EFFECTIVE AS OF FEBRUARY 7, 2025, BY AND AMONG O ea022991401ex10-6_oramed.htm EX-10.6 44648
8 PRESS RELEASE, DATED FEBRUARY 11, 2025 (FURNISHED PURSUANT TO ITEM 7.01) ea022991401ex99-1_oramed.htm EX-99.1 14680
12 GRAPHIC ex10-1_001.jpg GRAPHIC 100830
13 GRAPHIC ex10-1_002.jpg GRAPHIC 113743
14 GRAPHIC ex10-1_003.jpg GRAPHIC 2988
  Complete submission text file 0001213900-25-012244.txt   1699009

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ormp-20250207.xsd EX-101.SCH 3009
10 XBRL LABEL FILE ormp-20250207_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE ormp-20250207_pre.xml EX-101.PRE 22355
25 EXTRACTED XBRL INSTANCE DOCUMENT ea0229914-8k_oramed_htm.xml XML 3688
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 25610350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)